Lata Paliwal’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (3)


Figure 4: Effect of A. lebbeck and L. inermis hydromethanolic extracts on lymphocyte proliferation upon mitogenic stimulation
Total flavonoid content of ALE and LIE
Total phenolic content of ALE and LIE
Comparative analysis of Albizia lebbeck and Lawsonia inermis: Phytochemical estimation and their immunomodulatory effects
  • Article
  • Full-text available

December 2024

·

18 Reads

The Journal of Phytopharmacology

Salma Osman

·

Mohamedkhair Osman

·

Lata Paliwal

·

[...]

·

Indigenous knowledge holds valuable insights into medicinal plants and their traditional uses. Incorporating products derived from medicinal plants as natural antioxidants could play a crucial role in enhancing immunity and overall health. This study investigates the immunomodulatory effects of two plant hydromethanolic extracts viz., Albizia lebbeck (ALE) and Lawsonia inermis (LIE), utilizing a chicken lymphocytes culture model. Both plants were extracted using a hydromethanolic method, revealing significant phytochemical constituents, including flavonoids and phenolics. The percent yield of LIE (6.08%) was higher than that of ALE (5.44%). Phytochemical analysis indicated that ALE contained 124 µg rutin equivalents (RE)/mg of extract for flavonoids and 3.93 µg gallic acid equivalents (GAE)/mg for phenolics, while LIE showed 104.5 µg RE/mg and 1.84 µg GAE/mg, respectively. The maximum non-cytotoxic dose (MNCD) was established at 0.4 mg/ml for ALE and 0.2 mg/ml for LIE, beyond which both the extracts exhibited dose-dependent cytotoxicity. Both extracts enhanced T and B cell proliferation, significantly. These findings suggest that ALE and LIE possess significant immunomodulatory properties, potentially offering therapeutic applications in managing immunity-related conditions. Further research is warranted to elucidate their mechanisms of action and establish optimal dosages for clinical use.

Download

Fig. 1. CAR T-Cell Therapy and its Mechanism of Action
CAR T-Cell Therapies in Cancer
CAR T-Cell Therapy: Hope and Healing in the Battle Against Cancer

November 2024

·

23 Reads

Journal of Advances in Biology & Biotechnology

With numerous forms and a myriad of genetic and environmental factors, cancer continues to be a leading cause of morbidity and mortality worldwide. Advances in cancer research have led to a deeper understanding of the molecular mechanisms driving cancer progression, facilitating the development of targeted therapies and immunotherapies. Chimeric Antigen Receptor T-cell therapy, commonly known as CAR T-cell therapy, represents a groundbreaking approach in the field of cancer immunotherapy. This innovative treatment involves genetically engineering a patient's T cells to express chimeric antigen receptors (CARs) that target specific cancer cells. CAR-T therapy has demonstrated remarkable success in the treatment of certain hematologic malignancies, particularly B-cell malignancies like acute lymphoblastic leukaemia (ALL), chronic lymphocytic leukaemia (CLL), and non-Hodgkin lymphoma (NHL). CAR T-cell therapy also has challenges, such as managing side effects like cytokine release syndrome and neurotoxicity, high treatment costs, and the need for further research to broaden its applicability to solid tumours. CAR T-cell therapies, such as Kymriah and Yescarta, have demonstrated impressive clinical outcomes in patients with relapsed or refractory cancers, offering hope for those with limited treatment options. Additionally, the long-term durability of responses requires continuous monitoring and research.


Figure 1: Sleep Cycle Progression.
Figure 2: Type of GABA receptors
Figure 3: Benzodiazepine (BDZ) action on gaba receptor causes increase in Cl -ion influx.
Bioresources used as relaxants for the treatment of common sleep conditions.
Unveiling the Sleep-Immunity Nexus: Plant Bioresources for Ameliorating Consequences of Sleep Deprivation

August 2024

·

44 Reads

·

1 Citation

The Journal of Phytopharmacology

Sleep is a fundamental physiological process that not only supports immune function but also contributes significantly to overall well-being. Because of the established decline in the average amount of sleep due to lifestyle and rise in shift work over the past few decades, exploring the relationship between sleep and immunity has become crucial. Moreover, infections trigger increased sleep as a result of the host's immunological response, particularly the release of proinflammatory cytokines, such as tumour necrosis factor and interleukin-1. Understanding the mechanisms governing the human immune response against different pathogens during sleep, as well as the neuroimmune interconnections, immune regulatory effects of sleep, and the impact of cytokines in sleep deprivation, is crucial. Traditional medicine has employed plant derived preparations for treating various sleep disorders and promoting better sleep. While some plant derived products have shown positive effects on sleep, it is essential to acknowledge the limited scientific research in this area, and altered individual responses to these. In conclusion, recognizing the critical connection between sleep and immunity underscores the importance of prioritizing sufficient and restorative sleep to bolster overall health and well-being. While certain products may offer potential benefits for better sleep, further scientific investigation is necessary to fully understand their effectiveness and applicability on an individual basis.

Citations (1)


... Zinc has been shown to increase sleep quality, particularly when paired with magnesium. Though both Chamomile Flower (0.96 %) and Passion flower (0.81 %) contain minor levels of zinc, their presence may nonetheless contribute to sleep regulation, although indirectly (Paliwal & Ambwani, 2024). The purpose of this study was to assess the efficacy of Chamomile flower and Passion flower as therapies for primary insomnia using the Pittsburgh Sleep Quality Index (PSQI). ...

Reference:

Comparative effect of Chamomile flower (Matricaria chamomilla L.) andPassion flower (Passiflora incarnata L.) powder tea in patients suffering from primary insomnia
Unveiling the Sleep-Immunity Nexus: Plant Bioresources for Ameliorating Consequences of Sleep Deprivation

The Journal of Phytopharmacology